Small molecule may prevent metastasis in colorectal cancer
Colorectal cancer is deadliest when it metastasizes. It follows that the most effective way to…
Browsing: GI Cancers
Treating anal cancer precursor lesions reduces cancer risk for people with HIV
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research…
More accurately identifying colorectal cancer
In order to study colorectal cancer more efficiently, microbiome scientists from the University of Tartu…
New prediction models for colon cancer and advanced precancerous polyps are easy to use clinical and public health tools
Researchers have created novel scoring tools for predicting actual risk of colon cancer and advanced…
Study reveals rates of the most common form of liver cancer are rising in rural areas while slowing in urban areas
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the fastest-growing cause…
ESMO 2021: AtezoTRIBE study
Highlights on atezolizumab combined with FOLFOXIRI + bevacizumab in 1st-line metastatic colorectal cancer: AtezoTRIBE study
ESMO 2021: KRYSTAL-1 Study
Highlights on adagrasib in patients with KRASG12C-mutated colorectal cancer: The KRYSTAL-1 study
Scientists discover new pathway that prevents bowel cancer treatment from working
Leading scientists at the University of Birmingham, UK, have discovered a previously unknown pathway that…
Colon cancer risk extends to second- and third-degree relatives
Having second- or third-degree relatives with colorectal cancer increases a person’s risk of developing the…
ESMO 2021: Update on INVICTUS trial shows improved overall median survival in GIST patients using ripretinib
Results from the phase 3 INVICTUS clinical trial show that the drug ripretinib provides clinically…